Fierce Health listed NAD+ at $250 with monthly wording. Confirm whether the figure is a recurring monthly charge or tied to a longer plan, then check the supply amount, renewal terms and any separate fees before ordering.
standing rate, “Billed every 48 weeks”; standing rate, “Billed every 24 weeks”; standing rate, “Billed every 12 weeks”; standing rate, “Billed every 4 weeks”; standing rate, “Billed every 48 weeks” · 12-month tier labeled Billed every 48 weeks; upfront total not printed.; standing rate, “Billed every 24 weeks” · 6-month tier labeled Billed every 24 weeks; upfront total not printed.; standing rate, “Billed every 12 weeks” · 3-month tier labeled Billed every 12 weeks; upfront total not printed.; standing rate, “Billed every 4 weeks” · 1-month tier labeled Billed every 4 weeks; upfront total not printed.
The current comparison uses observations dated September 2026. Earlier observations remain separate from current offers.
Reading dates record when an offer was checked, not a guarantee of today’s price. Confirm the current product, supply and payment terms before ordering.
Price disclosure score: 85 of 100
This score measures the clarity of published price information. It does not rate the product, clinician, treatment quality or value for money.
Swipe or scroll to see all scoring details.
Fierce Health — price disclosure score, 85 of 100
What is scored
What Fierce Health publishes
Points
An exact figure
The headline figure is an exact charge for a defined purchase, not a floor and not a first-period rate.
30of 30
A stated cadence
The seller states the interval it bills on, so a reader knows when the next charge lands.
20of 20
Visible on the page
Every headline figure (1 figure) is printed where a reader can see it.
20of 20
A stated route
The seller states how the product is administered, in its own sentence.
15of 15
A stated dose
None of this seller's 3 figures states a dose, so no cost per milligram can be worked out from the page.
0of 15
Price disclosure score
This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value.